Nuvalent IncNASDAQ:NUVL
- LAST PRICE103.5600
- TODAY'S CHANGE (%)0.5400 (0.5242%)
- Bid / Lots98.5100/ 1
- Ask / Lots104.9700/ 1
- Open / Previous Close102.5200 / 103.0200
- Day Range
- 52 Week Range
- Volume301,764
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NUVL |
|---|---|---|
| 09:32 ET | 871 | 103.1 |
| 09:34 ET | 500 | 102.63 |
| 09:36 ET | 300 | 102.1 |
| 09:45 ET | 193 | 100.66 |
| 09:48 ET | 967 | 100.96 |
| 09:52 ET | 100 | 100.96 |
| 10:01 ET | 1060 | 101.615 |
| 10:03 ET | 1000 | 101.975 |
| 10:06 ET | 224 | 101.98 |
| 10:08 ET | 200 | 101.98 |
| 10:10 ET | 4463 | 102.37 |
| 10:12 ET | 500 | 102.81 |
| 10:14 ET | 200 | 102.97 |
| 10:21 ET | 500 | 103.21 |
| 10:24 ET | 1350 | 103.125 |
| 10:26 ET | 800 | 102.97 |
| 10:32 ET | 400 | 102.86 |
| 10:35 ET | 242 | 103.225 |
| 10:39 ET | 200 | 103.06 |
| 10:42 ET | 100 | 103.28 |
| 10:44 ET | 500 | 103.36 |
| 10:50 ET | 443 | 103.16 |
| 10:51 ET | 100 | 103.295 |
| 10:53 ET | 1351 | 103.27 |
| 10:55 ET | 143 | 103.11 |
| 10:57 ET | 1560 | 102.93 |
| 11:00 ET | 600 | 103.045 |
| 11:02 ET | 427 | 102.94 |
| 11:04 ET | 400 | 103.055 |
| 11:06 ET | 1000 | 103.28 |
| 11:09 ET | 1102 | 103.21 |
| 11:11 ET | 300 | 103.17 |
| 11:13 ET | 900 | 103.105 |
| 11:15 ET | 500 | 102.96 |
| 11:18 ET | 100 | 103.09 |
| 11:20 ET | 200 | 103.16 |
| 11:22 ET | 200 | 103.26 |
| 11:24 ET | 300 | 103.26 |
| 11:26 ET | 502 | 103.135 |
| 11:27 ET | 500 | 103.01 |
| 11:31 ET | 1700 | 103.035 |
| 11:33 ET | 648 | 103.07 |
| 11:36 ET | 800 | 103.09 |
| 11:38 ET | 1009 | 103.35 |
| 11:40 ET | 455 | 103.26 |
| 11:44 ET | 100 | 103.21 |
| 11:49 ET | 100 | 103.28 |
| 11:51 ET | 300 | 103.36 |
| 11:54 ET | 400 | 103.245 |
| 11:56 ET | 100 | 103.255 |
| 11:58 ET | 550 | 103.13 |
| 12:00 ET | 239 | 103.1 |
| 12:02 ET | 761 | 103.1 |
| 12:03 ET | 1100 | 103.1 |
| 12:05 ET | 240 | 103.105 |
| 12:07 ET | 31900 | 103.555 |
| 12:09 ET | 150 | 103.555 |
| 12:12 ET | 500 | 103.7 |
| 12:20 ET | 400 | 103.3 |
| 12:21 ET | 700 | 103.24 |
| 12:25 ET | 2016 | 103.54 |
| 12:30 ET | 900 | 103.7599 |
| 12:32 ET | 294 | 103.41 |
| 12:34 ET | 200 | 103.39 |
| 12:36 ET | 100 | 103.19 |
| 12:38 ET | 200 | 103.195 |
| 12:39 ET | 900 | 102.8801 |
| 12:43 ET | 250 | 103.1 |
| 12:45 ET | 100 | 103.1 |
| 12:48 ET | 5126 | 103.08 |
| 12:50 ET | 300 | 103.24 |
| 12:52 ET | 100 | 103.155 |
| 12:56 ET | 100 | 103.04 |
| 12:57 ET | 3000 | 103.04 |
| 12:59 ET | 100 | 103.11 |
| 01:01 ET | 200 | 103.1 |
| 01:03 ET | 400 | 103.1 |
| 01:06 ET | 1903 | 103.13 |
| 01:08 ET | 200 | 102.98 |
| 01:10 ET | 254 | 103.077 |
| 01:12 ET | 200 | 102.945 |
| 01:14 ET | 1105 | 102.745 |
| 01:17 ET | 900 | 102.92 |
| 01:21 ET | 200 | 103 |
| 01:24 ET | 100 | 102.8 |
| 01:28 ET | 505 | 102.97 |
| 01:30 ET | 6139 | 102.88 |
| 01:32 ET | 6575 | 102.88 |
| 01:33 ET | 1257 | 102.92 |
| 01:37 ET | 536 | 102.91 |
| 01:39 ET | 850 | 102.95 |
| 01:44 ET | 100 | 103 |
| 01:51 ET | 200 | 103.16 |
| 01:53 ET | 600 | 103.3 |
| 01:55 ET | 100 | 103.42 |
| 01:57 ET | 1150 | 103.375 |
| 02:08 ET | 600 | 103.2 |
| 02:09 ET | 875 | 103.19 |
| 02:11 ET | 100 | 103.07 |
| 02:13 ET | 200 | 102.99 |
| 02:18 ET | 400 | 102.95 |
| 02:20 ET | 100 | 102.95 |
| 02:24 ET | 100 | 102.9 |
| 02:26 ET | 600 | 103.03 |
| 02:27 ET | 250 | 102.89 |
| 02:29 ET | 400 | 102.525 |
| 02:33 ET | 200 | 102.48 |
| 02:38 ET | 2057 | 102.54 |
| 02:40 ET | 3266 | 102.84 |
| 02:54 ET | 200 | 102.73 |
| 02:58 ET | 1646 | 102.78 |
| 03:02 ET | 2420 | 103.2 |
| 03:03 ET | 200 | 103.145 |
| 03:07 ET | 300 | 102.945 |
| 03:09 ET | 100 | 102.85 |
| 03:12 ET | 100 | 102.91 |
| 03:14 ET | 400 | 102.86 |
| 03:16 ET | 100 | 102.79 |
| 03:18 ET | 611 | 102.874 |
| 03:20 ET | 100 | 102.91 |
| 03:21 ET | 200 | 102.88 |
| 03:23 ET | 490 | 102.87 |
| 03:25 ET | 2063 | 102.98 |
| 03:30 ET | 100 | 103.12 |
| 03:32 ET | 100 | 103.06 |
| 03:36 ET | 200 | 103.06 |
| 03:38 ET | 2200 | 103.49 |
| 03:39 ET | 906 | 103.28 |
| 03:43 ET | 398 | 103.02 |
| 03:45 ET | 1140 | 103.1 |
| 03:48 ET | 476 | 103.11 |
| 03:50 ET | 1100 | 103.31 |
| 03:52 ET | 1100 | 103.24 |
| 03:54 ET | 400 | 103.21 |
| 03:56 ET | 273 | 103.17 |
| 03:57 ET | 1036 | 103.23 |
| 03:59 ET | 36643 | 103.56 |
Sep 18, 2024
Nuvalent Announces Closing of Upsized Public Offering of Common Stock, from 4:05PM ET on Wednesday Sep 18, 2024 by Dow Jones
4:05PM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 17, 2024
DJ Nuvalent Down Over 6%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk, from 3:24PM ET on Tuesday Sep 17, 2024 by Dow Jones
3:24PM ET on Tuesday Sep 17, 2024 by Dow Jones
Sep 16, 2024
*DJ Nuvalent Prices Upsized Underwritten Public Offering of 5M Class A Shares at $100.00 Each >NUVL, from 10:32PM ET on Monday Sep 16, 2024 by Dow Jones
10:32PM ET on Monday Sep 16, 2024 by Dow JonesNuvalent Announces Pricing of Upsized Public Offering of Common Stock, from 10:23PM ET on Monday Sep 16, 2024 by Dow Jones
10:23PM ET on Monday Sep 16, 2024 by Dow JonesDJ Nuvalent Is Maintained at Buy by Guggenheim, from 12:54PM ET on Monday Sep 16, 2024 by Dow Jones
12:54PM ET on Monday Sep 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nuvalent Inc | 6.7B | -37.2x | --- |
Viking Therapeutics Inc | 6.9B | -69.0x | --- |
Cytokinetics Inc | 6.2B | -9.8x | --- |
Revolution Medicines Inc | 7.5B | -12.6x | --- |
Avidity Biosciences Inc | 5.7B | -16.0x | --- |
Krystal Biotech Inc | 5.2B | 48.6x | --- |
Company Information
Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. It develops small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases and drive more durable responses. It is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-positive non-small cell lung cancer, and multiple discovery-stage research programs. Its product candidate, NVL-520, is being developed for patients with ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer (NSCLC). NVL-520 is a novel ROS1-selective inhibitor. Its product candidate, NVL-655, is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC. LC. NVL-655 is a brain-penetrant ALK-selective inhibitor. Its product candidate, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor.
Contact Information
- Headquarters
- One Broadway, 14th FloorCAMBRIDGE, MA, United States 02142
- Phone
- 857-357-7000
- Fax
- 302-655-5049
Executives
- Non-Executive Independent Chairman of the Board
- Anna Protopapas
- President, Chief Executive Officer, Director
- James Porter
- Chief Financial Officer, Treasurer
- Alexandra Balcom
- Chief Development Officer
- Darlene Noci
- Chief Medical Officer
- Christopher Turner
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.7B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 65.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.78 |
Book Value | $10.94 |
P/E Ratio | -37.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
